UBS Assumes Inspire Medical Systems at Sell, Lowers Price Target of $39
Truist Securities Maintains Hold on Inspire Medical Systems, Raises Price Target to $54
Freedom Capital Markets Initiates Coverage of Inspire Medical Systems (INSP) with Buy Recommendation
Freedom Capital Markets Initiates Coverage On Inspire Medical Systems with Buy Rating, Announces Price Target of $62
Inspire Medical Systems, Inc. (INSP) Presents at Wells Fargo 2026 MedTech Innovation Spotlight Transcript
Evercore ISI Group Downgrades Inspire Medical Systems (INSP)
Evercore ISI Group Downgrades Inspire Medical Systems to In-Line, Lowers Price Target to $40
Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2026 MedTech Innovation Spotlight
Alphatec vs. Inspire Medical Systems: Which Healthcare Stock Is a Better Buy in 2026?
Why Is Inspire (INSP) Down 15.9% Since Last Earnings Report?
Is Inspire Medical Systems (INSP) Reset Creating A Potential Opportunity For Investors Now
Spotting Winners: Inspire Medical Systems (NYSE:INSP) And Medical Devices & Supplies - Specialty Stocks In Q1
Analyst warns Inspire Medical has a problem lasting into 2028
Inspire Medical Systems Faces Coding Overhang, Estimate Risks, BofA Says
Inspire Medical Systems (INSP) Price Target Decreased by 17.14% to 72.73
Inspire Medical Systems, Inc. (INSP) Presents at Bank of America Global Healthcare Conference 2026 Transcript
5 Insightful Analyst Questions From Inspire Medical Systems’s Q1 Earnings Call
Things Look Grim For Inspire Medical Systems, Inc. (NYSE:INSP) After Today's Downgrade
Inspire Medical Systems (INSP) Is Down 18.8% After Cutting 2026 Guidance Amid Reimbursement Challenges - What's Changed
Inspire Medical Systems, Inc. 2026 Q1 - Results - Earnings Call Presentation
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.